These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38972323)
1. Applying the EU regulatory framework for the clinical use of psychedelics. Butlen-Ducuing F; Silva F; Silva I; Balabanov P; Thirstrup S Lancet Psychiatry; 2024 Jul; ():. PubMed ID: 38972323 [No Abstract] [Full Text] [Related]
3. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry. Barber GS; Dike CC Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705 [TBL] [Abstract][Full Text] [Related]
4. Psychedelics in the treatment of unipolar and bipolar depression. Bosch OG; Halm S; Seifritz E Int J Bipolar Disord; 2022 Jul; 10(1):18. PubMed ID: 35788817 [TBL] [Abstract][Full Text] [Related]
5. Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review. Yu Z; Burback L; Winkler O; Xu L; Dennett L; Vermetten E; Greenshaw A; Li XM; Milne M; Wang F; Cao B; Winship IR; Zhang Y; Chan AW Front Psychiatry; 2024; 15():1386321. PubMed ID: 38807690 [TBL] [Abstract][Full Text] [Related]
6. Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis? Andrews CM; Hall W; Humphreys K; Marsden J Addiction; 2024 Jun; ():. PubMed ID: 38845381 [TBL] [Abstract][Full Text] [Related]
8. Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review. Zhornitsky S; Oliva HNP; Jayne LA; Allsop ASA; Kaye AP; Potenza MN; Angarita GA Front Psychiatry; 2023; 14():1197890. PubMed ID: 37435405 [TBL] [Abstract][Full Text] [Related]
9. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis. Dourron HM; Strauss C; Hendricks PS Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878 [TBL] [Abstract][Full Text] [Related]
10. Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis. Basedow LA; Majić T; Hafiz NJ; Algharably EAE; Kreutz R; Riemer TG Sci Rep; 2024 Jun; 14(1):14782. PubMed ID: 38926480 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans. Heal DJ; Gosden J; Smith SL Neuropharmacology; 2018 Nov; 142():89-115. PubMed ID: 29427652 [TBL] [Abstract][Full Text] [Related]
13. The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry. Kurtz JS; Patel NA; Gendreau JL; Yang C; Brown N; Bui N; Picton B; Harris M; Hatter M; Beyer R; Sahyouni R; Diaz-Aguilar LD; Castellanos J; Schuster N; Abraham ME Cureus; 2022 Sep; 14(9):e29167. PubMed ID: 36259015 [TBL] [Abstract][Full Text] [Related]
14. Beating pain with psychedelics: Matter over mind? Elman I; Pustilnik A; Borsook D Neurosci Biobehav Rev; 2022 Mar; 134():104482. PubMed ID: 34922987 [TBL] [Abstract][Full Text] [Related]
15. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. de Vos CMH; Mason NL; Kuypers KPC Front Psychiatry; 2021; 12():724606. PubMed ID: 34566723 [TBL] [Abstract][Full Text] [Related]
16. Neural Geometrodynamics, Complexity, and Plasticity: A Psychedelics Perspective. Ruffini G; Lopez-Sola E; Vohryzek J; Sanchez-Todo R Entropy (Basel); 2024 Jan; 26(1):. PubMed ID: 38275498 [TBL] [Abstract][Full Text] [Related]
17. Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties. Atiq MA; Baker MR; Voort JLV; Vargas MV; Choi DS Psychopharmacology (Berl); 2024 May; ():. PubMed ID: 38743110 [TBL] [Abstract][Full Text] [Related]
18. Attitudes of European psychiatrists on psychedelics: a qualitative study. Žuljević MF; Breški N; Kaliterna M; Hren D Front Psychiatry; 2024; 15():1411234. PubMed ID: 38855648 [TBL] [Abstract][Full Text] [Related]
19. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study. Song-Smith C; Jacobs E; Rucker J; Saint M; Cooke J; Schlosser M BMJ Open; 2024 Mar; 14(3):e083595. PubMed ID: 38485474 [TBL] [Abstract][Full Text] [Related]
20. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics. Kucsera A; Suppes T; Haug NA Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]